These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19652593)

  • 1. Detection of HER-2 and EGFR gene amplification using chromogenic in-situ hybridization technique in ovarian tumors.
    Lee ES; Lee Y; Suh D; Kang J; Kim I
    Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):69-74. PubMed ID: 19652593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of HER-2 Gene Amplification and Protein Expression in Benign, Borderline, and Malignant Ovarian Serous and Mucinous Neoplasms.
    Mohammed RAA; Makboul R; Elsers DAH; Elsaba TMAM; Thalab AMAB; Shaaban OM
    Int J Gynecol Pathol; 2017 Jan; 36(1):50-57. PubMed ID: 27309616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [EGFR and HER2 gene expression status and their correlation in non-small cell lung cancer].
    Zeng X; Wu SF; Zhou WX; Li DJ; Gao J; Liang ZY; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):398-402. PubMed ID: 17069674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma.
    Sholl LM; John Iafrate A; Chou YP; Wu MT; Goan YG; Su L; Huang YT; Christiani DC; Chirieac LR
    Mod Pathol; 2007 Oct; 20(10):1028-35. PubMed ID: 17673923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR gene copy number heterogeneity in fine-needle aspiration cytology from breast carcinomas determined by chromogenic in situ hybridization.
    Sauer T; Beraki K; Noren T; Garred O; Naess O
    Diagn Cytopathol; 2005 Oct; 33(4):228-32. PubMed ID: 16138375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.
    Wu Y; Soslow RA; Marshall DS; Leitao M; Chen B
    Gynecol Oncol; 2004 Dec; 95(3):570-5. PubMed ID: 15581965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of chromogenic in situ hybridization for epidermal growth factor receptor gene copy number detection in non-small-cell lung carcinomas: a comparison with fluorescence in situ hybridization study.
    Yoo SB; Lee HJ; Park JO; Choe G; Chung DH; Seo JW; Chung JH
    Lung Cancer; 2010 Mar; 67(3):301-5. PubMed ID: 19505745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary.
    Ross JS; Yang F; Kallakury BV; Sheehan CE; Ambros RA; Muraca PJ
    Am J Clin Pathol; 1999 Mar; 111(3):311-6. PubMed ID: 10078105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.
    Tanner M; Gancberg D; Di Leo A; Larsimont D; Rouas G; Piccart MJ; Isola J
    Am J Pathol; 2000 Nov; 157(5):1467-72. PubMed ID: 11073807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma.
    Lassus H; Leminen A; Vayrynen A; Cheng G; Gustafsson JA; Isola J; Butzow R
    Gynecol Oncol; 2004 Jan; 92(1):31-9. PubMed ID: 14751135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy.
    Marquez A; Wu R; Zhao J; Tao J; Shi Z
    Diagn Mol Pathol; 2004 Mar; 13(1):1-8. PubMed ID: 15163002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cell regulatory proteins in ovarian borderline tumors.
    van Haaften-Day C; Russell P; Boyer CM; Kerns BJ; Wiener JR; Jensen DN; Bast RC; Hacker NF
    Cancer; 1996 May; 77(10):2092-8. PubMed ID: 8640675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue microarray analysis of EGFR and erbB2 copy number changes in ovarian tumors.
    Dimova I; Zaharieva B; Raitcheva S; Dimitrov R; Doganov N; Toncheva D
    Int J Gynecol Cancer; 2006; 16(1):145-51. PubMed ID: 16445625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma.
    Lassus H; Sihto H; Leminen A; Joensuu H; Isola J; Nupponen NN; Butzow R
    J Mol Med (Berl); 2006 Aug; 84(8):671-81. PubMed ID: 16607561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplicon profiles in ovarian serous carcinomas.
    Nakayama K; Nakayama N; Jinawath N; Salani R; Kurman RJ; Shih IeM; Wang TL
    Int J Cancer; 2007 Jun; 120(12):2613-7. PubMed ID: 17351921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.
    Ettl T; Stiegler C; Zeitler K; Agaimy A; Zenk J; Reichert TE; Gosau M; Kühnel T; Brockhoff G; Schwarz S
    Hum Pathol; 2012 Jun; 43(6):921-31. PubMed ID: 22154363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the amplification and expression of c-erbB2 oncogene in epithelial ovarian tumors].
    Hou Y; Wang M; Liu W
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):426-8. PubMed ID: 9387293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing.
    Vanden Bempt I; Van Loo P; Drijkoningen M; Neven P; Smeets A; Christiaens MR; Paridaens R; De Wolf-Peeters C
    J Clin Oncol; 2008 Oct; 26(30):4869-74. PubMed ID: 18794552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor (EGFR) gene copy number detection in non-small-cell lung cancer; a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization.
    Gallegos Ruiz MI; Floor K; Vos W; Grünberg K; Meijer GA; Rodriguez JA; Giaccone G
    Histopathology; 2007 Nov; 51(5):631-7. PubMed ID: 17927584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome.
    Woelber L; Hess S; Bohlken H; Tennstedt P; Eulenburg C; Simon R; Gieseking F; Jaenicke F; Mahner S; Choschzick M
    J Clin Pathol; 2012 Feb; 65(2):133-9. PubMed ID: 22128196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.